Recent Posts
- Illinois Attorney General Files Lawsuit Against HIV/AIDS Nonprofit
- California Gov. Arnold Schwarzenegger Signs Budget That Cuts $52M From HIV/AIDS Programs
- Efforts Underway In Namibia To Treat Pediatric HIV
- HIV/AIDS Education Project Targeting Pennsylvania Black Women Examined
- Also In Global Health News: Uganda Male Circumcision; Malaria Vaccine; Potential Global Fund Grant In Cambodia; PMTCT Of HIV In Botswana
Random Posts
- Op-Eds: Pharma In Africa; U.S. Global TB Funding; ITN Distribution Strategies Examined
- Global AIDS Coordinator Goosby Believes Zimbabwe's Ailing Health System Can Be Strengthened
- Amarillo, Texas To Use State Grant For HIV Surveillance Activities
- New Survey Targets Over 50s Living With HIV, UK
- In Kidney Disease Caused By HIV, A Protein Excreted In Urine May Be Help In Diagnosis
- Male Circumcision Programmes As Part Of Combination HIV Prevention In Sub-Saharan Africa Are Cost Effective, Says UNAIDS
- Routine Circumcision Does Not Protect Against HIV For Men Who Have Sex With Men, CDC Study Finds
- Ghana's Justice Minster Calls For Workplace HIV, TB Policies
- University Of Utah Researchers Testing Gel That May Help Prevent Spread Of HIV
- FDA Approves Labeling Update For REYATAZ(R) Capsules To Include 96-Week Data For Previously Untreated HIV-1 Infected Adult Patients
Prescription AIDS Drugs
Contact Us
The Mystery Of Why HIV Patients Are More Susceptible To TB Infection Solved By Harvard Scientists
July 06th, 2009
A team of Harvard scientists has taken an important first step toward the development of new treatments to help people with HIV battle Mycobacterium tuberculosis (TB) infection. In their report, appearing in the July 2009 print issue of the Journal of Leukocyte Biology they describe how HIV interferes with the cellular and molecular mechanisms used by the lungs to fight TB infection. This information is crucial for researchers developing treatments to help people with HIV prevent or recover from TB infection.
“HIV/TB co-infection is a critical global health problem, especially in developing countries,” said Naimish Patel, M.D., lead researcher on the study and Instructor of Medicine at Beth Israel Deaconess Medical Center and Harvard Medical School. “We hope that these findings will lead to further studies and possible new therapies for treating or preventing tuberculosis in HIV disease.”
Patel and colleagues made their discovery by extracting immune cells called “alveolar macrophages” from the lungs of otherwise healthy, asymptomatic HIV-positive patients as well as from people who did not have HIV. In people who are HIV-positive, the macrophages have a decreased response to the TB bacterium when compared to people who did not have HIV. To learn why, the scientists examined lung specimens from the HIV-positive patients and found increased levels of a molecule called IL-10, which elevated the amount of a protein called “BCL-3″ in alveolar macrophages and that reduced their ability to ward off TB infection.
“HIV and TB represent two of the most significant health challenges in human history and the combination of the two infections is particularly devastating because HIV dramatically increases the severity of TB infection,” said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology, “There are still many unknowns about how HIV reduces the ability of the body to combat other infections. This study sheds light on co-infection with HIV and TB, which up to this point, has perplexed scientists and physicians alike.”
Source:
Cody Mooneyhan
Federation of American Societies for Experimental Biology
Related posts:
- Key To Strengthening Immune Response To Chronic Infection Discovered By Wistar Scientists A team of researchers from The Wistar Institute has identified...
- How Key Protein Keeps Chronic Infection In Check Why is the immune system able to fight off some...
- Certain Cancers More Common Among HIV Patients Than Non-HIV Patients Researchers at UT Southwestern Medical Center have found that non-AIDS-defining...
- Gladstone Scientists Identify Key Factor That Controls HIV Latency Scientists at the Gladstone Institutes of Virology and Immunology (GIVI)...
- Virus Responsible For Deadly Brain Disease Found In MS Patients Treated With Natalizumab The virus responsible for PML (progressive multifocal leukoencephalopathy), a...
Related posts brought to you by Yet Another Related Posts Plugin.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.